Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioMarin Pharmaceutical Inc. - Common Stock
(NQ:
BMRN
)
58.99
+1.17 (+2.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioMarin Pharmaceutical Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
↗
May 18, 2024
Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.
Via
The Motley Fool
Topics
Stocks
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
↗
May 17, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 15, 2024
Via
Benzinga
Analyst Ratings For Biomarin Pharmaceutical
↗
May 14, 2024
Via
Benzinga
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
↗
May 09, 2024
Via
Benzinga
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
↗
April 25, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
↗
April 03, 2024
Via
Benzinga
The Latest Analyst Ratings For Biomarin Pharmaceutical
↗
February 23, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
↗
May 09, 2024
If you have the appetite for the risk inherent in the biotech sector, here are three biotech stocks to buy in May.
Via
InvestorPlace
Citi Just Cut Its Price Target on These 3 Stocks
↗
May 03, 2024
Reviewing analyst downgrades may help safeguard investment portfolios amid market uncertainty and Citi price target cuts.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
↗
April 30, 2024
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
Via
Chartmill
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
↗
April 27, 2024
Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.
Via
The Motley Fool
Topics
Stocks
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
↗
April 25, 2024
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.
Via
InvestorPlace
Recap: Biomarin Pharmaceutical Q4 Earnings
↗
February 22, 2024
Via
Benzinga
Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical
↗
January 30, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
↗
December 21, 2023
Via
Benzinga
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
April 25, 2024
Via
Benzinga
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
↗
April 24, 2024
BMRN stock results show that Biomarin Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 24, 2024
Via
Benzinga
Don't overlook NASDAQ:BMRN—a stock with solid growth prospects and a reasonable valuation.
↗
April 08, 2024
Investors seeking growth at a reasonable cost should explore BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN).
Via
Chartmill
While growth is established for NASDAQ:BMRN, the stock's valuation remains reasonable.
↗
March 18, 2024
Despite its growth, BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) remains within the realm of affordability.
Via
Chartmill
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
↗
March 16, 2024
Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.
Via
The Motley Fool
Topics
Stocks
Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN.
↗
February 26, 2024
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
Via
Chartmill
7 Biotech Stocks Fighting America’s Deadliest Diseases
↗
February 08, 2024
Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $200 Right Now
↗
February 07, 2024
A reasonably small amount of money can go a long way when it's put to work in innovative, industry-leading businesses.
Via
The Motley Fool
4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
↗
January 20, 2024
A greater than 7% decline in the Nasdaq Composite from its record high signals that opportunistic investors can still find bargains.
Via
The Motley Fool
Topics
Stocks
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
↗
January 10, 2024
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.
Via
InvestorPlace
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
↗
December 02, 2023
An 11% decline in the Nasdaq Composite over the past two years is an open invitation for opportunistic growth investors to go shopping.
Via
The Motley Fool
Topics
Stocks
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
↗
November 09, 2023
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.
Via
InvestorPlace
3 Promising Biotech Stocks Flying Under the Radar
↗
November 08, 2023
Breakthroughs in healthcare are happening everyday, make sure you are keeping up to date on these under the radar biotech stocks.
Via
InvestorPlace
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
